Camelia Monoranu
-
- Parkinson's Disease Mechanisms and Treatments 3
- Vascular Malformations Diagnosis and Treatment 3
- Neurofibromatosis and Schwannoma Cases 2
-
- Parkinson's Disease Mechanisms and Treatments 3
- Vascular Malformations Diagnosis and Treatment 3
- Neurofibromatosis and Schwannoma Cases 2
-
- Genetic Neurodegenerative Diseases 3
- Nerve injury and regeneration 2
-
- Glioma Diagnosis and Treatment 7
-
- Meningioma and schwannoma management 2
-
- Moyamoya disease diagnosis and treatment 1
- Co-authors
- Peter RiedererJeswinder Sian‐HülsmannGiles H. VinceThomas WestermaierCordula MatthiesK. RoosenRalf‐Ingo ErnestusThomas Linsenmann
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Camelia Monoranu
16 papers receiving 167 citations
Peers
Comparison fields: 5 of 56
- Neurology 76
- Neurology 24
- Cellular and Molecular Neuroscience 50
- Biological Psychiatry 5
- Genetics 17
Countries citing papers authored by Camelia Monoranu
This map shows the geographic impact of Camelia Monoranu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camelia Monoranu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camelia Monoranu more than expected).
Fields of papers citing papers by Camelia Monoranu
This network shows the impact of papers produced by Camelia Monoranu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camelia Monoranu. The network helps show where Camelia Monoranu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Camelia Monoranu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 14 | |
| 4 | 2021 | 51 | |
| 5 | 2020 | 0 | |
| 6 | Clinical value of [18F]FET-PET/CT in pediatric patients with primary central nervous sytem tumors | 2020 | 1 |
| 7 | 2020 | 8 | |
| 8 | 2019 | 9 | |
| 9 | 2019 | 2 | |
| 10 | 2018 | 7 | |
| 11 | [18F]FET-PET/CT as a prognostic factor in newly-diagnosed gliomas II and III | 2018 | 1 |
| 12 | 2016 | 1 | |
| 13 | 2015 | 8 | |
| 14 | 2015 | 28 | |
| 15 | 2013 | 15 | |
| 16 | 2012 | 1 | |
| 17 | 2012 | 6 | |
| 18 | 2009 | 15 |
About Camelia Monoranu
Camelia Monoranu is a scholar working on Genetics, Neurology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 168 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Genetic Neurodegenerative Diseases (3 papers), Vascular Malformations Diagnosis and Treatment (3 papers), Meningioma and schwannoma management (2 papers), Nerve injury and regeneration (2 papers), Neurofibromatosis and Schwannoma Cases (2 papers) and Moyamoya disease diagnosis and treatment (1 paper). The work is most often cited by research in Neurology (76 citations), Neurology (24 citations) and Cellular and Molecular Neuroscience (50 citations). Camelia Monoranu has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Peter Riederer, Jeswinder Sian‐Hülsmann, Giles H. Vince, Thomas Westermaier, Cordula Matthies, K. Roosen, Ralf‐Ingo Ernestus, Thomas Linsenmann, Matthias Meinhardt and Mario Löhr.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.